{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:13:33Z","timestamp":1761822813264},"reference-count":47,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,8,18]],"date-time":"2005-08-18T00:00:00Z","timestamp":1124323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>All adult patients with Burkitt lymphoma or lymphoblastic lymphoma should receive central nervous system (CNS)\u2010directed therapy with both intrathecal and high\u2010dose systemic chemotherapy. There is no evidence to support the routine use of prophylactic CNS\u2010directed therapy in any specific subgroup of adult patients with \u2018low grade\u2019 lymphomas. There are some anatomical sites where involvement by lymphoma is associated with a higher risk of CNS relapse. These probably include testis, breast, paranasal sinuses and the epidural space. Multivariate analyses strongly support a raised serum lactate dehydrogenase level and the involvement of more than one extranodal site as the strongest predictors of subsequent CNS relapse. A high International Prognostic Index score may replace the use of the above two factors in combination. There is evidence of good efficacy when intrathecal chemotherapy and high\u2010dose systemic chemotherapy are used in combination. It is not clear how the best balance between the \u2018sensitivity\u2019 and \u2018specificity\u2019 of the choice of patients to receive CNS\u2010directed therapy can be achieved.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2005.05703.x","type":"journal-article","created":{"date-parts":[[2005,9,14]],"date-time":"2005-09-14T15:48:51Z","timestamp":1126712931000},"page":"13-21","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Central nervous system\u2010directed preventative therapy in adults with lymphoma"],"prefix":"10.1111","volume":"131","author":[{"given":"Andrew","family":"McMillan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,9,20]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V91.4.1178","article-title":"Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate\u2010grade and immunoblastic lymphoma","volume":"91","author":"Van\u2010Besien K.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.4.485"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199112000-00004"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2001.n.017"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.8.2479"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008260120532"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000067909"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V47.1.3.3"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/030089168106700108"},{"key":"e_1_2_4_11_1","first-page":"282","article-title":"Hematological neoplasms with first presentation as spinal cord compression syndromes: a 10\u2010year retrospective series and review of the literature","volume":"22","author":"Chahal S.","year":"2003","journal-title":"Clinical Neuropathology"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000006475"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.6.2091.bloodjournal8662091"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh013"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<154::AID-CNCR21>3.0.CO;2-T"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000079195"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008394827806"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.16.3025"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-05-1982"},{"key":"e_1_2_4_22_1","first-page":"540","article-title":"New approaches to acute lymphoblastic leukemia in adults: where do we go","volume":"27","author":"Hoelzer D.","year":"2000","journal-title":"Seminars in Oncology"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(00)00171-4"},{"key":"e_1_2_4_24_1","volume-title":"WHO Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue","author":"Jaffe E.S.","year":"2001"},{"key":"e_1_2_4_25_1","first-page":"61","article-title":"Biochemical and pharmacologic rationale for high\u2010dose methotrexate","volume":"5","author":"Jolivet J.","year":"1987","journal-title":"NCI Monographs"},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.3109\/02841869609084002"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800201)45:3<545::AID-CNCR2820450322>3.0.CO;2-6"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900080305"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V54.6.1249.1249"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820201)49:3<586::AID-CNCR2820490331>3.0.CO;2-C"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.3.925"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf253"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031770"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-003-0737-2"},{"key":"e_1_2_4_35_1","first-page":"401","article-title":"Immunoglobulin diseases. (Basis of modern immunology. Clinical contribution. Bing\u2010Neel syndrome)","volume":"76","author":"Pennacchio L.","year":"1969","journal-title":"Policlinico Sezione Practica"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-2095"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-2094"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.2.355.355"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1636"},{"key":"e_1_2_4_40_1","first-page":"342","article-title":"Evaluation of central nervous system involvement in nasal lymphomas","volume":"61","author":"Shikama N.","year":"2001","journal-title":"Nippon Igaku Hoshasen Gakkai Zasshi"},{"key":"e_1_2_4_41_1","first-page":"238","article-title":"The prophylaxis of meningeal leukemia with intrathecal methotrexate","volume":"54","author":"Spevak J.","year":"1964","journal-title":"Journal of Iowa Medical Society"},{"key":"e_1_2_4_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2"},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0542"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1985.tb02724.x"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyg072"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909058415"},{"key":"e_1_2_4_47_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008313229892"},{"key":"e_1_2_4_48_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.141"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2005.05703.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2005.05703.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:40:38Z","timestamp":1697380838000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2005.05703.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,20]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1111\/j.1365-2141.2005.05703.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05703.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,20]]},"assertion":[{"value":"2005-09-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}